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Abstract
Trophoblast differentiation and formation of the placenta are important events linked to post-
implantation embryonic development. Models mimicking the biology of trophoblast differentiation
in a post-implantation maternal microenvironment are needed for understanding disorders like
placental-ischemia or for applications in drug-screening, and would help in overcoming the ethical
impasse on using human embryos for such research. Here we attempt to create such a model by
using embryoid bodies (EBs) and a biomimetic platform composed of a bilayer of fibronectin and
gelatin on top of low-melting agarose. Using this model we test the hypothesis that cystic-EBs (day
30) that resemble blastocysts morphologically, are better sources as compared to noncytic EBs
(day 10), for functional trophoblast differentiation; and that the Rho kinases inhibitor Y27632 can
enhance this differentiation. Non/cytic EBs with/out Y27632 were grown on this platform for 28
days, and screened from secretion and expression of trophoblast and other lineage markers using
ECLIA, RT-PCR, and Immunofluorescence. All EBs attached on this surface and rapidly proliferated
into hCG and progesterone (P2) secreting functional trophoblast cells. However, the cells derived
from cytic-EBs and cytic-EBs+ Y27632 showed the maximum secretion of these hormones and
expressed IGF2, supporting our hypothesis. Also Y27632 reduced extraembryonic endoderm and
trophoblast lineage differentiation from early noncystic-EBs, whereas, it specifically enhanced the
induction of trophoblast and multinucleated syncitiotrophoblast differentiation from late cystic-
EBs. In vivo trophoblast differentiation can be replicated in fibronectin based biomaterials, using
cytic-EBs and by maneuvering the Rho-ROCK pathways. Response of EBs to a compound may vary
temporally, and determination of their right stage is crucial for applications in directed-
differentiation or drug-screening.
Introduction
During preimplantation development, the embryos at the
blastocyst stage form a polarized layer of outer epithelial
cells called the trophectoderm [1]. Post-implantation this
trophectoderm differentiate into mesenchymal like tro-
phoblast cells [1]. The trophoblast cells invade through
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the maternal endometrium and proliferate in the mater-
nal stromal cells while initiating a decidual reaction at the
site of implantation [1]. The trophoblast cells are the pre-
cursors for the placenta that would develop latter [1].
Understanding the mechanism of placental cell differenti-
ation and formation is important for developing interven-
tions related to poor placental formations and birth
defects. With a regenerative medicine point of view it
would be fascinating to have placental cells growing in
cultures, which could be employed for supporting preg-
nancies during medical conditions like placental ischemia
or pre-eclampsia.
Human embryonic stem cells (hESCs) are known to have
the ability to differentiate into embryonic and extraem-
bryonic lineages, and have been used as models to under-
stand lineage differentiation for a long time. They help in
overcoming the ethical impasse on the use of human
embryos for such research [2]. These cells are either sub-
jected to directed differentiation on regular 2-dimentional
cultures, or in suspension cultures, where they grow as 3-
dimensional spheres known as embryoid bodies (EBs).
These EBs mimic peri-implantation embryos in lineage
composition, and are often used as the starting material
for directed differentiation protocols. However, depend-
ing on the lineage induction time lines in these EBs may
or may-not be suitable or more effective for deriving a spe-
cific lineage. We have therefore used EBs at two different
stages; early EBs and late cystic-EBs (i.e., EBs which have
developed a fluid filled cavity like that of a blastocyst) to
compare their efficiency of trophoblast cell differentia-
tion. Here we test the hypothesis that the cystic-EBs being
morphologically similar to a blastocyst, may have an
inherent ability to differentiate towards trophoblast cells
and would be a better starting material for inducing such
differentiations of extraembryonic trophoblast, or endo-
derm lineages. Human ESCs readily differentiate to pla-
cental precursor cells during in vitro culture [3,4].
However, many of the currently used differentiation pro-
tocols involve growth factors and conditions that have not
been identified or found to be irrelevant to the differenti-
ation process in vivo. Such differentiation protocols there-
fore limit our ability to understand the molecular
mechanisms of placenta formation in vivo. We have
therefore tried to develop a differentiation protocol based
on Y27632 a commonly used inhibitor of the Rho -
kinases, molecular players, which are known for their
roles in trophectoderm and trophoblast formations in
vivo.
Rho-family GTPases (such as RhoA, Rac1, and CDC42)
regulate trophectoderm differentiation, cell polarity [5]
and E-cadherin expression in cleavage stage embryos and
a variety of other cell types [6]. Rho kinases (ROCK) are
downstream effectors of the Rho GTPases. Inhibition of
the ROCK activity can reduce or enhance cell polarity or
differentiation in a dose dependent manner. Y27632 a
known inhibitor of the Rho kinases (10 M) can also
improve human embryonic stem cell colonogenicity in
small colonies [7]. The role of ROCK in differentiation of
hESCs and the cells in the EBs is not entirely clear.
Here we have tried to mimic the embryonic developmen-
tal stages and the differentiation process by more than one
way. First we have used cystic embryoid bodies which
resemble blastocysts as a starting material for differentia-
tion. These entities which are close to a late blastocyst in
terms of having a similar fluid filled cyst/cavity, were
found to be better than early EBs without any cysts. Sec-
ond we have used a biomimetic platform which is rich in
matrix proteins like fibronectin found in the endometrial
stroma [8]. Third we have tried to derive and direct tro-
phoblast differentiation by controlling the Rho-kinase sig-
naling pathways which is well known for it role in
differentiation. This model therefore would be useful to
understand trophoblast differentiation and screen com-
pounds for potential developmental toxicity.
Materials and methods
Regular culture of hESCs on MEFs and feeder free cultures 
on Matrigel
Human embryonic stem cell lines HUES7 and 9 were used
after institutional ethics committee approval. The cultures
were maintained as described in our previous publica-
tions [9].
Induction of embryoid bodies (EBs)
For induction of embryoid body (EB) formation, the
hESC were seeded on low-adherent 60 mm plate (BD Bio-
sciences, San Jose, CA,) containing ES media without
FGF2. Human ESCs from three confluent 35 mm dishes
were collected after trypsinization and used for inducing
EBs in each 60 mm low-adherent dishes. Culture media
was changed every two days. Early EBs without any cavi-
ties was collected on day 10 of culture. Cytic EBs were col-
lected on day 30 of culture.
Selection of dose of Y27632 for hESC cultures
A commonly used dose of 20 M Y27632was used for
testing its effect on trophoblast differentiation. The com-
pound was added to the regular culture media for cytic
and non-cytic EBs after plating them on the biomimetic
platforms.
Preparation of the biomimetic platform
Low melting agarose (Sigma, St. Louis, MO) 0.05% was
coated (0.1 mm thick) on 35 mm dishes, after 15 minutes
at room temperature, this was then layered with a coating
of gelatin 0.01% (Sigma, St. Louis, MO) in PBS. This was
further coated by a top layer of Fibronectin (Sigma, St.Journal of Biomedical Science 2009, 16:88 http://www.jbiomedsci.com/content/16/1/88
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Louis, MO) diluted to 0.005% using DMEM. 1 ml of this
solution was added to the 35 mm culture dishes. The
dishes were allowed to stay overnight at 25°C (room tem-
perature). On the next day the fibronectin was aspirated
and the plates were gently washed with the culture media
twice. These platforms were equilibrated with DMEM
overnight in a CO2 incubator before putting the EBs for
outgrowth.
Outgrowth of EBs into monolayers
Early noncystic and late cystic EBs were collected on days
10 and 30 respectively. They were washed in the culture
media and were divided into groups of about 20 each.
Each group was then grown in continuous presence of 20
M Y27632, and allowed to attach and outgrow on our
biomimetic platform. A control group of EBs (n = 20) was
allowed to grow and attach without any Y27632 supple-
mentation. The presence of all the germ lineages in the
day 10 and 30 EBs were confirmed by RT-PCR analyses.
Directed differentiation of the EBs to functional 
trophoblast cells
Day 10 and day 30 old EBs were collected and divided
into treated and control groups. The treated EBs (n = 40)
were grown in the continuous presence of 20 M Y27632
over a period of 28 days. The control group (n = 40) was
left unexposed to Y27632 and grown till 28 days. About
10 EBs were seeded in each of the biomimetic platforms
for the control and treated groups. The rate of attachment
of the EBs and their areas of outgrowth leading to an
adherent monolayer of cells was carefully observed and
monitored under a phase contrast inverted microscope
(Nikon).
The culture media were changed every 4 days. 1 ml of the
culture supernatants were collected from the control and
treated culture dishes every 4 days from day 1 to day 28.
The secretion of functional trophoblast specific hormones
hCG and progesterone was measured using electrochemi-
luminescence immunoassay "ECLIA". Similarly the cul-
ture/spent media were also analyzed for Alfa feto protein
(AFP) to detect signs of extraembryonic endoderm differ-
entiation. The expression profile of some of the common
pluripotency, ectoderm, endoderm, mesoderm and tro-
phectoderm lineage markers like Oct4, Nanog, HMGB1,
III-tubulin, GATA4, BMP2, Brachury, GCM1 and -hCG
etc. were studied by RT-PCR in the control and treated
cells to confirm differentiation. These adherent monol-
ayer of trophoblast cells were also studied for immunolo-
calization of early human trophectoderm and endoderm
markers like SSEA1 and Cytokeratin-18. The trophoblast
like characteristic of these cells was also confirmed by
GCM1, Hand 1, IGF2 and GMC1 mRNA expression in the
control and the Y27632-treated monolayers of cells.
Electrochemiluminescence immunoassay "ECLIA"
The culture supernatants collected were tested for func-
tional trophectoderm and endoderm differentiation by
testing the presence of intact hCG+  subunit, Progesteron
II (P2), and AFP. The analyses were done using electro-
chemiluminescence immunoassay (ECLIA) for these mol-
ecules using Roche Elecsys Cobas diagnostic kits (Catalog
numbers: 03271749, 12145383 and 04481798). The
assays were carried out following the manufactures
instructions, and were analyzed on the Roche Elecsys
2010 (Roche Diagnostics GmbH, Indianapolis, IN, USA)
immunoassay analyzer.
RT-PCR
Total RNA from cells was isolated using TRIZOL-LS Rea-
gent (Invitrogen) as per the manufacturer's protocol.
Complementary DNA was synthesized using the Super-
Script III First-Strand Synthesis System (Invitrogen) as per
the manufacturer's instructions. Polymerase Chain Reac-
tion (PCR) was carried out using 1 U Taq DNA Polymer-
ase (Sigma) and MgCl2 to a final concentration of 1.5 mM
in a total volume of 25 l/reaction. -actin was used as the
housekeeping control. PCR cycles consisted of an initial
denaturation at 95°C for 5 minutes followed by 35 ampli-
fication cycles of denaturation at 94°C for 45 seconds,
annealing for 45 seconds, and extension at 72°C for 45
seconds and final extension at 72°C for 10 minutes. The
RT-PCR primers, amplicon sizes, and their annealing tem-
peratures are given in Table 1.
Immunofluorescence
EBs were grown on coverslips coated with the biomimetic
platform as per requirement. The cells were fixed with 4%
paraformaldehyde (Sigma) followed by permeabilization
in 0.2% Triton X100 (Sigma). The slides were then incu-
bated with primary antibodies 1:500 dilution of SSEA1
(Santa Cruz Biotechnology, CA, USA), and Cytokeratin 8/
Troma1 (R&D Systems, Minneapolis, USA) overnight at
4°C. After washing thrice with PBS, fluorescein isothiocy-
anate/Texas red- labeled Secondary antibodies against the
primary goat/rabbit/mouse were added as 1:500 dilutions
and incubated for 2 hours. DAPI (Sigma) was used for
nuclear staining and then washed with PBS. The negative
controls were done without primary antibodies. Slides
were mounted with DABCO (Sigma) and images were
acquired using Nikon Eclipse 90 i microscope (Nikon
Corporation, Japan) and Image-Pro Express software
(Media Cybernetics, Inc, Silver Spring, MD).
Statistical analysis
We have used Student's t-test (paired or unpaired) as
appropriate, for calculation of statistical significance.
Error bars on the graphs show standard deviation of three
or more replicates (n = 3) or samples. Values were consid-Journal of Biomedical Science 2009, 16:88 http://www.jbiomedsci.com/content/16/1/88
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ered statistically significant only when P  < 0.05, and
highly significant when P < 0.005.
Results
Embryoid bodies were made from hESC cultures grown
feeder free for atleast one passage to get rid of any contam-
inating MEFs. We found that the early noncystic EBs (Fig
1a) and late cystic EBs (Fig 1b) showed a difference in
their propensity to adhere to the designed biomimetic
platform. About 80% of the early day 10 non cytic EBs
attached to the platforms by day 2, the rest of them
attached by day 4, and the first signs of cells spreading out
were observed from this day. The late cytic EBs attached
faster to these surfaces, and about 95% of them attached
to this biomimetic surface by late day 1, the remaining
cytic EBs attached and started outgrowing by day 3. The
EBs from both groups when exposed to the continuous
presence of 20 M Y27632 showed enhanced and
improved attachment and outgrowth rates. 20 M
Y27632 induced about 90% attachments in both the
groups, by day 2. Fig. 1c shows an attached late cystic EB
which has outgrown in presence of 20 M Y27632.
Secretion of hCG, P2 and AFP in noncystic EBs
The amount of functional extraembryonic lineage differ-
entiation was measured by secretion of hCG and proges-
Table 1: List of genes and RT-PCR primers used
Gene Sequence Annealing Temperature (°C) Product Size(bp)
Oct 4 CGACCATCTGCCGCTTTGAG
CCCCCTGTCCCCCATTCCTA
57 572
Nanog CCTCCTCCATGGATCTGCTTATTCA
CAGGTCTTCACCTGTTTGTAG
57 262
GAPDH GGGCGCCTGGTCACCAGGGCTG
GGGGCCATCCACAGTCTTCTG
60 531
IIITubulin CTTGGGGCCCTGGGCCTCCGA
GGCTTCCTGCAGTGGTACACGGGCG
60 174
GATA4 TCCAAACCAGAAAACGGAAG
CTGTGCCCGTAGTGAGATGA
60 187
Brachury ACCCAGTTCATAGCGGTGAC
ATGAGGATTTGCAGGTGGAC
60 216
BMP2 TGTATCGCAGGCACTCAGGTCAG
AAGTCTGGTCACGGGGAAT
60 328
GATA2 TGACTTCTCCTGCATGCACT
AGCCGGCACCTGTTGTGCAA
60 244
HAND1 TGCCTCAGAAAGAGAACCAG
ATGGCAGGATGAACAAACAC
60 274
BMP4 GTCCTGCTAGGAGGCGCGAG
GTTCTCCAGATGTTCTTTCG
60 339
hCG GCTACTGCCCCACCATGACC
ATGGACTCGAAGCGCACATC
55 95
GCM1 CGGAAACGCTGTCCCAACT
CCCTTCAGGCTCAATGAGACG
57 235
IGF2 CAATGGGGAAGTCGATGCTG
CTTGGCGAGCACGTGAC
61 421
FGFR1 GGACTCTCCCATCACTCTGCAT
CCCCTGTGCAATAGATGATGATC
56 109Journal of Biomedical Science 2009, 16:88 http://www.jbiomedsci.com/content/16/1/88
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terone (trophoblast) and AFP (endoderm) in the culture
supernatants. The early day 10 EBs showed high levels of
secretion of hCG from day 12 onwards. The secretion of
hCG peaked at day 20, and started falling after that (Fig.
2a). The 20 M Y27632 treated cultures however, showed
no such rise, and the secretion of hCG remained steady
from day 8 to day 28 without any significant raise. These
secretion levels were very significantly lower than the con-
trol levels on day 12 to 28. However, the secretion of hCG
was triggered a bit earlier i.e., by day 8, in the 20 M
Y27632 treated samples, as compared to day 12 in the
control.
The secretion of progesterone (P2) in the control cultures
followed a similar pattern as that of hCG, with a steady
raise in it levels from day 12 onwards (Fig. 2b). Also, the
level of P2 steadily fell from day 20 to 28. We observed
that 20 M Y27632 treatment initiated the secretion of P2
earlier i.e., by day 8, as compared to day 12 in the control
samples. P2 levels were significantly higher than the con-
trol in the 20 M Y27632 treated samples up to day 16,
and started falling from there. The highest levels of P2
secretion was again found at day 20 in the control sam-
ples.
The secretion of AFP was found to be very high from day
12 to 28 in the control as compared to the 20 M Y27632
treated (Fig 2c). The highest level of AFP secretion was
found on day 16 and 20 in the control. These were very
significantly higher than that in the 20 M Y27632 treated
cultures.
Secretion of hCG, P2 and AFP in cytic EBs
The cystic EBs were then checked for their potential to dif-
ferentiate into functional extraembryonic trophoblast and
endoderm lineages. Unlike the day 10 early noncytic EBs
these EBs showed several hundred fold increase in the
secretion of hCG both in the control and treated groups
(Fig 2d). The secretion of hCG steadily raised from day 8,
peaked at day12 and 16, and rapidly fell at day 20 in the
Trophoblast differentiation from embryoid bodies on the biomimetic platform Figure 1
Trophoblast differentiation from embryoid bodies on the biomimetic platform. Panel (a) shows a non-cystic early 
EB. Panel (b) shows a late cytic EB with clear fluid filled cavity (red arrow) and a small mass of cells similar to inner cell mass 
(ICM) of an embryos (green arrowhead) pushed towards the top. Panel (c) shows a cystic EB outgrowing on the biomimetic 
platform on day 16. Panels (d) and (e) immunolocalization of trophoblast markers cytokeratin 8/Troma1 (red) and SSEA1 
(green) in cytic EB outgrowths at early day 8. Blue (DAPI stain) represent the nuclei. This shows the evidences for the first 
signs for clear and distinct trophoblast cell differentiation from cystic EBs as early as day 8.Journal of Biomedical Science 2009, 16:88 http://www.jbiomedsci.com/content/16/1/88
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control. Following this a steady secretion of hCG was
maintained from day 20 t0 28. The 20 M Y27632 treated
samples exhibited a similar trend with several folds higher
secretions on day 16, as compared to the control. The
secretion levels in these 20 M Y27632 treated cultures
fell down significantly on day 20, and remained steady
from day 20 to 28. However, the secretion levels of hCG
in the 20 M Y27632 treated cultures were significantly
higher than the control from day 12 onwards.
The secreted levels of P2 in the control cultures followed
a similar pattern as that of hCG in the control (Fig 2d and
2e). The peak secretion in the control cultures were seen
on day 12, and was about 2 folds over the peak P2 levels
obtained in the control cultures from noncystic EBs on
day 20. The secretion of P2 was triggered early i.e., from
day 4 onwards in the cystic EBs cultures treated with 20
M Y27632. This effect is similar to that of in noncystic EB
cultures treated with 20 M Y27632. A sharp increase in
P2 secretion was seen on day 8 in 20 M Y27632 treated
cultures. From day 12 to day 16 the level of P2 in the 20
M Y27632 treated cultures remained significantly lower
than the control. From day 20 to 28 the secretion of P2 in
the control and treated cultures remained almost the same
with no significant variations.
The secretion of AFP increased steadily from day 8 to 16
in both the treated and control groups (Fig 2f). The high-
est secretion was seen on day 16 in both the groups. The
highest levels of AFP secretion from the cytic EBs were up
by almost two folds as compared to that in non cystic
early EBs (Fig 2c). The 20 M Y27632 treated groups had
significantly lower levels of AFP secretion as compared to
the control. The levels of AFP decreased significantly from
day 16 to 20 in both groups. While the group treated with
20 M Y27632 maintained a very reduced levels of AFP,
the control group showed a significant raise in AFP secre-
tion again by day 28.
Characterization of the trophoblast cells
The cells were characterized in the 20 M Y27632 treated
cultures of cystic EBs as early as day 8 i.e., from the day
Secretion of trophoblast and lineage markers Figure 2
Secretion of trophoblast and lineage markers. Graphs (a), (b) and (c) indicates secretion of hCG, progesterone (P2) and 
AFP from control and Y27632 treated outgrowth cultures from non-cystic early day 10 EBs. Graphs (d), (e) and (f) indicates 
secretion of hCG, progesterone (P2) and AFP from control and Y27632 treated outgrowth cultures from cystic late day 30 
EBs. The values are represented as mean ± SD. Level of secretion in the treated cultures are marked by (*) and (**) to indicate 
significant (P < 0.05) and highly significant (P < 0.005) differences as compared to the control.Journal of Biomedical Science 2009, 16:88 http://www.jbiomedsci.com/content/16/1/88
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these cells started showing hCG and P2 secretions. RT-
PCR analysis showed the expression of all the lineage and
pluripotency markers with highest expression for the tro-
phoblast markers likeGMC1, HAND1 etc. Immunofluo-
rescence analysis of the trophoblast markers SSEA1 and
Cytokeratin 8/Troma1 was also done. The EBs clearly
showed cells positively for distinct surface localized
SSEA1 and cytoplasmic and peripheral Troma1 in the cells
surrounding the outgrowing cytic EBs (Fig 1d and 1e).
Noncystic EBs did not show distinct expression for these
markers on day 8 (data not shown). The immunolocaliza-
tion of Cytokertin 8 also indicated that some of these tro-
phoblast cells were multinucleated and were probably
advancing towards the development of sincytiotrophob-
lasts.
To confirm that Y27632 downregulated AFP expression
we tested the expression of AFP mRNA in the control and
Y27632 treated cultures from cytic EBs on day 12 of out-
growth. We found that the expression of AFP was almost
negligible in the Y27632 treated samples, and showed a
strong band in the control samples (Fig 3). The levels of -
actin expression in both samples were found to be similar.
Another interesting feature of a functional post implanta-
tion trophoblast is the expression of IGF2 [10]. The
expression of IGF2 was therefore tested in the day 12 sam-
ples of control and treated cultures. We found strong
expression of IGF2 mRNA levels in the Y27632 treated
samples as compared to the control (Fig 3). As described
above the amounts of -actin expression in both the sam-
ples were found to be similar and shows the semiquanti-
tative nature of these estimations.
Discussion
Human embryonic stem cell lines can differentiate spon-
taneously or directed towards trophoblast lineages by cul-
turing them in presence of BMP4 [3]. Feeder free hESC
cultures on matrigel in presence of mouse embryonic
fibroblast conditioned medium (MEF-CM) and basic
fibroblast growth factor (FGF2) readily respond to BMP
family members by differentiating into trophoblast cells
within a few days. Alternatively, trophoblast differentia-
tion can be obtained from embryoid bodies inserted into
matrigel rafts and cultured in absence of FGF2 and MEF-
CM for up to 8 weeks (wk) [4]. A common factor in the
two major protocols, developed so far, resulting in pro-
nounced trophoblast cell differentiation was the inclusion
of Matrigel, a complex extracellular matrix rich in laminin
and other undefined regulatory molecules like TGF etc.
Matrigel also lacks the stromal milieu needed to provide a
stromal environment. Also no evidence for the role of
BMPs in TB differentiation in vivo in embryos is known so
far. Use of human embryonic stem cell (hESC) as a model
to study the molecular players underpinning TB differen-
tiation is therefore presently limited by the use of 1) unde-
fined culture microenvironment for TB differentiation, 2)
growth factors which are not yet shown to be implicated
in trophectoderm differentiation during embryogenesis
and 3) use of either human ESCs or EBs which may not be
the right starting material that mimic perimplantation
embryonic development.
In this study we have attempted to devise a more defined
culture environment by providing a porous surface coated
with known biological matrix. Gelatin a derivative of col-
lagen and fibronectin are the components of the maternal
stromal microenvironment. To have a defined culture
condition the differentiation of EBs to trophoblast cells
were done in culture media supplemented with knock out
serum [11]. The uterine decidual or stromal cells provide
an environment for growth and proliferation of the invad-
ing trophoblast cells of the implanting embryos [8].
Fibronectin has been implicated as a major player mediat-
ing the maternal fetal interactions and facilitate the tro-
phoblast invasion [8]. The embryoid bodies attached
better on our fibronectin coated surfaces (data not
Semiquantitative RT-PCR comparing the level of expression  of AFP and IGF2 mRNA in control and Y27632 treated cytic  EB cultures on day 16 Figure 3
Semiquantitative RT-PCR comparing the level of 
expression of AFP and IGF2 mRNA in control and 
Y27632 treated cytic EB cultures on day 16. The 
expression of AFP was seen to be stronger in the control 
(very faint band) as compared to treated cultures. However, 
expression of IGF2 a characteristic of trophoblast cells was 
seen to be stronger in the treated as compared to the con-
trol (faint band). The expression of -actin was similar in 
both control and treated samples.Journal of Biomedical Science 2009, 16:88 http://www.jbiomedsci.com/content/16/1/88
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shown), as compared to normal tissue culture dishes,
however, no signs of invasion into the gel was seen.
Presence of 20 M Y27632 increased the rate of attach-
ment and differentiation of trophoblast differentiation
from the hESCs. Y27632 inhibits the Rho A, Rho Kinases,
MLC kinase pathway, and activate the alternative CDC42
and Rac pathways. These pathways are also involved in
maintaining pluripotency in hESCs [12]. These molecules
are well known for their role in trophoblast cell migration
and in determining cell polarity and in epithelial mesen-
chymal transitions [13]. The rate of attachment and the
area of outgrowth were significantly higher in the Y27632
treated samples. The treated cells secreted higher amounts
of hCG and P2 in the culture media. RT-PCR studies
showed a reduced or loss of expression of the germ lineage
markers (data not shown). However, a positive expression
of trophoblast markers like hCG and IGF2 was found.
This study for the first time indicates that Y27632 can be
used for the induction of endocrinologically active synci-
tiotrophoblast like cells in a defined culture microenvi-
ronment. This also leads to the development of a model
where trophoblast differentiation and proliferation is
controlled by a known factor which plays a similar role in
embryonic development [14].
It was equally important for us to have the right hESC
based starting material that would be similar in lineage
composition and characteristics of a post implantation
embryo. This is essential for the model to reflect the in vivo
developmental events closely. HESCs and their EBs are
known to have different lineage compositions at different
time points. Early stage EBs are composed of cells from all
the three germ layers [2]. However, the localization and
distribution of these germ cells in these three dimensional
structures are not well studied across various hESC lines.
We have seen that late EBs on the other hand have struc-
tures which are morphjologically closer to a preimplanta-
tion blastocyst. These EBs often known as the cytic EBs
have a fluid filled blastocoel like cavity and also have a
mass of cells resembling the inner cell mass pushed to on
side (Fig 1b). Our study showed that cytic EBs produced
more trophoblast lineage cells than early noncytic EBs.
The fact that Y27632 can exert differential effects on early
noncytic and late cystic EBs, indicates clearly that differen-
tiation protocols, developmental studies, and drug screen-
ing protocols using EBs need to be designed keeping their
temporally changing behavior in mind. I an earlier study
we have shown that lipopolysaccharide (LPS) exposure
could lead to a permanent silencing of mesoderm lineage
induction in early EBs, by further screening the EBs at very
late time points, we confirmed that this molecule did not
simply delay the induction of mesoderm lineage in the
EBs [2].
However, the potential of the hESC derived trophoblast
cells to give rise to other placental cell types like the vil-
lious and extravillous TB cells remains to be tested. We
have seen that the cells harvested from day 8 or 12 of out-
growth from cytic EBs can be expanded on fibronectin
and gelatin coated plates for a few passages. We are now
trying to see if trophoblast stem cells lines and other pla-
cental cells could be transdifferentiated from these pri-
mary cells. Our study clearly shows that the time points
with highest hCG and P2 secretions may indicate the time
when the cells should be harvested and taken to the next
passage for deriving a trophoblast stem cell line. Such
attempts are currently being undertaken in our laboratory.
Conclusion
Understanding the molecular mechanisms of TB differen-
tiation in embryos or from hESCs will help in devising
better processes for directing differentiation of hESCs
towards trophoblast and other placental lineages. Devel-
opment of better biomaterial based three dimensional
porous scaffolds micro-environments that mimic the
endometrial stromal microenvironment, where trophob-
last cells would invade into the biomimetic material and
proliferate, is required. It would be important to use
fibronectin, collagen1 and other stromal matrices to
develop such platforms. Such advances will help in devel-
oping drug screening platforms that would also help in
answering questions that are currently limited by the eth-
ical impasse on using human embryos.
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